Beam Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.908; its P/E ratio is -13.59; Beam Therapeutics is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-1.42. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 316.19M	$ 17.19M	$ 20.12M	$ 24.21M	$ 20.04M
Gross Profit	$ 316.19M	$ 17.19M	$ 20.12M	$ 24.21M	$ 20.04M
EBIT	$ 144.16M	$ -96.09M	$ -82.78M	$ -96.46M	$ -64.41M
EBITDA	$ 149.53M	$ -90.90M	$ -77.96M	$ -91.81M	$ -60.46M
Net Income Common Stockholders	$ 142.80M	$ -96.09M	$ -82.78M	$ -96.46M	$ -38.35M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 435.89M	$ 1.02B	$ 1.07B	$ 1.06B	$ 232.77M
Total Assets	$ 1.46B	$ 1.29B	$ 1.35B	$ 1.33B	$ 1.34B
Total Debt	$ 172.69M	$ 173.98M	$ 177.13M	$ 178.86M	$ 182.01M
Net Debt	$ -263.21M	$ -841.48M	$ -895.89M	$ -880.61M	$ -50.76M
Total Liabilities	$ 478.38M	$ 511.59M	$ 542.24M	$ 570.85M	$ 608.24M
Stockholders Equity	$ 981.33M	$ 778.94M	$ 811.64M	$ 761.51M	$ 733.47M
Cash Flow	-
Free Cash Flow	$ 131.48M	$ -97.73M	$ -100.85M	$ -115.83M	$ -77.45M
Operating Cash Flow	$ 135.07M	$ -89.78M	$ -84.67M	$ -109.81M	$ -69.19M
Investing Cash Flow	$ 98.10M	$ -10.23M	$ -41.48M	$ 25.45M	$ 113.44M
Financing Cash Flow	$ 33.71M	$ 36.78M	$ 107.54M	$ 98.42M	$ 32.01M

Currency in USD

Beam Therapeutics Earnings and Revenue History

Income Statement >

Beam Therapeutics Debt to Assets

Balance Sheet >

Beam Therapeutics Cash Flow

Cash Flow >

Beam Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing